Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
PURPOSE To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN Observational case series. METHODS Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.